Drug
Ndv 3 Investigational Vaccine
Ndv 3 Investigational Vaccine: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| NDV-3 investigational vaccine NCT01273922 | Phase 1 | Staphylococcal Infections |
Latest
No recent events.
Follow Ndv 3 Investigational Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.